ELV250117P450000
- 65.90
- 0.000.00%
Elevance Health Newsroom
Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
Netflix, United Airlines, and More to Watch This Week
Obamacare Enrollments Exceed 24M in 2025, a Record High
Earnings Preview: ELV to Report Financial Results Pre-market on January 23
Weekly Buzz: Finally a Good Week for 2025
Wall Street Today: Trump's on Deck After Market Nearly Hits Year High
Live Stock News: Market Climbs, TikTok Ban Confirmed, Intel for Sale, Week Ends with Positivity
Does Elevance Health (ELV) Have a Promising Long-Term Outlook?
Unveiling Elevance Health (ELV) Q4 Outlook: Wall Street Estimates for Key Metrics
Fund Update: Perpetual Ltd Just Disclosed New Holdings
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On?
Here's How Much $100 Invested In Elevance Health 20 Years Ago Would Be Worth Today
Wall Street Today: Thursday Earnings Looked a Lot More Mixed, and Philly is Booming
Healthcare Stocks Fall After UnitedHealth Posts Higher Medical Costs -- WSJ
UnitedHealth (UNH) CEO Eyes Simplified Healthcare in Challenging Landscape
Live Stock News: Sideways Trading Market After Big TSMC, UNH Earnings, Philly Economy is Booming
UnitedHealth Posts Rare Quarterly Miss Amid Rising Medical Expenses
Express News | CVS Health Shares Down About 4%, Elevance Health Down 3.2%, Humana Shares Fall About 3% and Cigna Down 2% Premarket
Express News | Shares of Some US Health Insurers Decline Premarket After UnitedHealth Reports Fourth-Quarter Revenues Below Estimates
Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $501